HKDC1 and type 2 diabetes mellitus: Further investigation should be conducted to ascertain whether this mechanism holds true in more clinical T2D-induced colon tumor patients, or whether LF inhibits the progression of the two diseases via acting on WTAP/m6A/NT5DC3/HKDC1 axis in the clinical area.